Page last updated: 2024-11-05

heptabarbital

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

heptabarbital: was heading 1976-94 (see under BARBITURATES 1976-90); HEPTABARBITONE was see HEPTABARBITAL 1976-94; use BARBITURATES to search HEPTABARBITAL 1976-94; intermediate or short term barbiturate used mainly for sedation and hypnosis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10518
CHEMBL ID468837
CHEBI ID81297
SCHEMBL ID713359
MeSH IDM0224837

Synonyms (46)

Synonym
heptabarbital [inn]
heptabarbo
heptabarbe
unii-v10r70ml23
v10r70ml23 ,
heptabarb [inn]
2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(1-cyclohepten-1-yl)-5-ethyl-
heptabarbital
5-(1-cycloheptenyl)-5-ethylbarbitursaeure
5-(1-cyclohepten-1-yl)-5-ethyl-2,4,6(1h,3h,5h)-pyrimidinetrione
noctyn
5-ethyl-5-cycloheptenylbarbituric acid
heptabarbo [inn-spanish]
heptamalum
medomin
barbituric acid, 5-(1-cyclohepten-1-yl)-5-ethyl-
medomine
einecs 208-107-6
heptbarbital
cycloheptenylethylbarbituric acid
medapan
g 475
5-ethyl-5-(1'-cycloheptenyl)-barbituric acid
heptabarbe [inn-french]
cycloheptenylethylmalonylurea
heptamal
heptabarbum [inn-latin]
heptadorm
heptabarbum
5-(1-cyclohepten-1-yl)-5-ethylbarbituric acid
heptabarb
heptabarbitone
DB01354
5-(cyclohepten-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione
C17725
509-86-4
CHEMBL468837
chebi:81297 ,
heptabarb [who-dd]
heptabarbital [mi]
SCHEMBL713359
5-(cyclohepten-1-yl)-5-ethylbarbituric acid
PAZQYDJGLKSCSI-UHFFFAOYSA-N
5-(cyclohept-1-en-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione
DTXSID10198927
Q410829

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"A personal computer based program (DDAPD1) was developed for calculating or determining the apparent distribution function of a drug to a possibly heterogeneous biophase, the mean transit time of a drug at the biophase, the ratio of distribution clearance to biophase volume of distribution, the drug concentration-time function at the biophase (Cb(t)), and a function which reflects the relationship between the pharmacodynamic response and Cb(t) of the drug."( A computer program using disposition decomposition analysis in pharmacodynamics.
Cheng, H; Gong, Y; Jusko, WJ, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
barbituratesMembers of the class of pyrimidones consisting of pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) and its derivatives. Largest group of the synthetic sedative/hypnotics, sharing a characteristic six-membered ring structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID384955Intrinsic aqueous solubility at pH 10 by shake-flask method2008Journal of medicinal chemistry, May-22, Volume: 51, Issue:10
Molecular characteristics for solid-state limited solubility.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (84.62)18.7374
1990's1 (7.69)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.16 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]